Objective: The mechanisms underlying the association of the increased albumin excretion rate (AER) with adiposity have yet to be clarified. We therefore investigated (1) the predictors of AER after 3 months of lifestyle intervention in a large cohort of nondiabetic obese women and (2) the relationships between AER and the adipose tissue gene expression of adipokines linked to inflammation and insulin resistance. Subjects: A total of 269 obese nondiabetic women (age 49.9 ± 13.1 years, body mass index (BMI) 36.8 ± 4.6 kg m À2 ) participated in this program. Measurements used were anthropometrics parameters, blood pressure, oral glucose tolerance test, lipids, creatinine, AER, homeostasis model assessment of insulin resistance (HOMA-IR) and glomerular filtration rate at baseline and after 3 months of lifestyle intervention. At baseline, in a subgroup of 34 women, subcutaneous adipose tissue biopsy was carried out for the analysis of mRNA expression levels of adiponectin, suppressor of cytokine signaling 3 (SOCS-3), tumor necrosis factor a (TNF-a), pentraxine 3 (PTX-3), angiotensinogen and angiotensin-converting enzyme, and a blood sample was also taken from this group for the measurement of circulating adiponectin, interleukin-6, TNF-a and PTX-3. Microalbuminuria was defined as albumin/creatinine ratio X3.5 mg mmol À1 . Real-time PCR was used to quantify mRNA. Results: Six percent of obese women had microalbuminuria. When dividing the whole cohort into three groups according to AER changes (decrease, stability and increase), we noted that 2 h glucose, insulin and HOMA-IR significantly decreased (Po0.05 for all) only in women who had a decrease in AER, whereas BMI and waist circumference significantly decreased in all the three groups (Po0.05). At baseline, higher AER was associated to significantly higher adipose tissue mRNA expression levels of SOCS-3 and PTX-3 (Po0.05) and to higher TNF-a and angiotensinogen expression. Conclusions: In obese women, weight loss alone is not sufficient to induce the AER decrease that occurs only with a concomitant improvement in glucose homeostasis. The adipose tissue gene expression profile seems to favor the early renal impairment often seen in obese subjects.
Introduction
Obese subjects often present increased levels of albumin excretion rate (AER) that indicate early renal impairment 1 and elevated risk of cardiovascular (CV) morbidity and mortality. [2] [3] [4] In the general population, microalbuminuria mostly occurs in nondiabetic and nonhypertensive individuals with a prevalence that increases with total and central adiposity. [5] [6] [7] [8] Moreover, a collaborative analysis of 57 prospective studies has recently shown that each 5 kg/m 2 higher body mass index (BMI) is associated with about 60% higher mortality for non-neoplastic kidney diseases. 9 However, the mechanisms underlying the association of adiposity with the increased AER have yet to be clarified. Some evidences suggested that in obesity, AER increases as a consequence of the hemodynamic effects such as increased renal blood flow and glomerular pressure with glomerular hyperfiltration and thereby an increased permeability to albumin. 10 Accordingly, the decrease in AER observed after gastroplasty-induced weight loss has been ascribed to the decrease in glomerular filtration rate (GFR) and fractional albumin clearance more than to the reduction in blood pressure (BP) and glucose. 11 In addition, the AER changes observed in a small group of obese patients after 1-year lifestyle modification-metformin program were shown to be associated with changes in creatinine clearance rather than in levels of BP, lipids and insulin. 12 Albuminuria is regarded as manifestation of a diffuse endothelial dysfunction that is favored by an inflammatory state. Indeed, human and experimental animal models of diabetic nephropathy are characterized by elevated levels of serum and urine inflammatory cytokines. 13, 14 It is therefore plausible that the chronic inflammatory state that characterizes obese subjects has a function in the development of microalbuminuria. This hypothesis is supported by the observation in the general population that changes in AER due to weight changes are associated to modifications in vascular inflammation rather than in the classical CV disease factors. 8 Despite these evidences, the relationships between adipose tissue products and AER have been poorly investigated and are unclear. For example, serum levels of the most abundant adipokine, adiponectin, have been shown to have both positive and negative relations with GFR and proteinuria in patients with chronic renal diseases. [15] [16] [17] In vitro studies in mice kidney glomerulus, however, support the hypothesis that adiponectin exerts a protective function against the development of microabuminuria through a reduction of oxidative stress and fusion of podocyte foot processes. 18 We therefore decided to investigate (1) the predictors of AER changes after 3 months of lifestyle intervention in a large cohort of nondiabetic obese women, and (2) the relationships between AER and adipose tissue gene expression of adipokines linked to inflammation and insulin resistance.
Patients and methods
A total of 269 obese nondiabetic women were recruited among those referred to the Istituto Auxologico Italiano for lifestyle modification program. For the cohort to be homogeneous, due to the low number of obese men participating in the lifestyle intervention program, we decided to analyze only women.
Obese women were studied before and after 3 months of intensive lifestyle intervention that consisted of weekly visits for education, advice reinforcement in dietary and exercise management and peer group psychological support. Clinical history (smoking habits, use of medications) and anthropometric measures (BMI and waist circumference) were collected and body composition assessed using bioimpedance analysis (BIA 101; RJL Systems Akern Srl, Florence, Italy). BP was measured three times every 5 min with a standard mercury sphygmomanometer and a cuff size optimized for arm circumference. Phase I and V (disappearance) Korotkoff sounds were used to identify systolic BP (sBP) and diastolic BP (dBP), respectively.
A 75 g oral glucose tolerance test (OGTT) was performed for measurement of plasma glucose and insulin concentrations, and a fasting blood sample was obtained for lipids and creatinine measurement. A morning urine sample was collected on four occasions (two at baseline and two after the intervention) 1-2 weeks apart for AER measurement and mean of two measurements was used for the analysis. Microalbuminuria was defined as an albumin/creatinine ratio X3.5 mg mmol
À1
. GFR was estimated using the recalibrated version of the four-variable Modification of Diet in Renal Disease study equation. 19 The homeostasis model assessment of insulin resistance (HOMA-IR) (fasting insulin Â fasting glucose/22.5) was used as a surrogate marker of insulin resistance. Impaired fasting glucose (IFG) was defined by fasting glucose levels X100 and o126 mg per 100 ml, impaired glucose tolerance (IGT) by 2 h glucose levels X140 and o200 mg per 100 ml and diabetes by 2 h glucose levels X200 mg per 100 ml. Women with BPX130/85 mm Hg or on antihypertensive therapy were defined hypertensive. High triglycerides and low highdensity lipoprotein (HDL) cholesterol were defined by levels X150 mg per 100 ml and o50 mg per 100 ml, respectively, or lipid-lowering therapy.
To examine if AER was associated with adipose tissue expression of adipokines, we determined the mRNA expression levels of adiponectin, suppressor of cytokine signaling 3 (SOCS-3), tumor necrosis factor a (TNF-a), pentraxine 3 (PTX-3), angiotensinogen and angiotensin-converting enzyme (ACE) in subcutaneous adipose tissue (SAT) of a subgroup of the 269 nondiabetic obese women. This group was composed by 34 nondiabetic obese women who gave their informed consent to the adipose tissue biopsy in the last 4 months of recruitment.
SAT samples were obtained through a periumbilical needle aspiration biopsy under local anesthesia before starting the lifestyle intervention. In this group of obese women, a blood sample for the measurement of adiponectin, and interleukin-6 (IL-6), TNF-a and PTX-3 was also taken.
The study was approved by the ethics committee of the Istituto Auxologico Italiano, and written informed consent was obtained from all women.
Biochemical measurements
Circulating levels of glucose, cholesterol, triglycerides and creatinine were measured using an automated analyzer (Roche Diagnostics, Mannheim, Germany). Insulin was measured by chemiluminescent immunometric assay (Diagnostic Products Corporation, Los Angeles, CA, USA) with a sensitivity of 2 mU l À1 and intra-and inter-assay CV of 3.3 and 4.1%, respectively. Adiponectin was determined by an enzyme-linked immunosorbent assay (B-Bridge International Inc., San Jose, CA, USA) with a sensitivity of 0.37 ng ml À1 and intra-and inter-assay CV of 3.3 and 7.4%, respectively. TNF-a was determined by a solid-phase Enzyme Amplified Sensitivity Immunoassay kit (BioSource Europe SA, Nivelles, Belgium) with a sensitivity of 3 pg ml À1 and the intra-and inter-assay CV of 5.2 and 9.9%, respectively. IL-6 was measured by an enzyme immunoassay using a monoclonal
Predictors of microalbuminuria in obesity L Gilardini et al antibody (R&D System Inc., Minneapolis, MN, USA) with a sensitivity of 0.7 pg ml À1 and intra-and inter-assay CV 4.2 and 6.4%, respectively. PTX-3 was determined using a sandwich enzyme immunoassay as previously described. 20 Urine albumin excretion was determined by immunoturbidimetric assay (Roche Diagnostics) with a sensitivity of 3 mg l À1 and intra-and inter-assay CV 1.3 and 4.3%, respectively.
RNA analysis of SAT Total RNA from adipose tissue was extracted using minicolumn purification procedure (RNeasy Mini Kit, Qiagen GmbH, Hilden, Germany) according to manufacturer's procedures. Concentration and quality of total RNA were evaluated by spectrophotometric determination and integrity by agarose gel analysis. From 1 mg of total RNA, cDNAs were reverse transcribed with SuperScript III (Invitrogen, Carlsbad, CA, USA). Real-time PCR was used to quantify mRNA. For each sample, 10 ng of template was amplified in triplicate in PCR on an ABI PRISM 7700 machine using Assay-onDemand Gene Expression Products (Applied Biosystems, Foster City, CA, USA). TaqMan probes (Applied Biosystems) for adiponectin, SOCS-3, TNF-a, PTX-3, angiotensinogen, ACE and the housekeeping gene b-glucuronidase (GUSB) mRNA were labeled with carboxyfluorescein. Analyses were performed with SDS 3 software (Applied Biosystems). The relative amount of the mRNA of interest was normalized to the amount of GUSB transcript in the samples, and data were expressed as 2 -DCT
Statistical analysis
Variables that were not normally distributed were log transformed for the analysis and expressed as median (interquartile range). Differences between groups were calculated using Student's t-test for independent samples or MannWhitney analysis. Frequencies were compared using a w 2 -test. Paired t-test was used to compare variables before and after intervention.
Spearman's correlation analyses were used to evaluate bivariate relationships. Analysis of variance was used to compare differences among tertiles of changes in AER. Multiple regression analysis was performed using variables that changed in a statistically significant way in the tertiles of AER.
All analyses were performed using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA). Data are expressed as mean ± s.d. or median (interquartile range). A P-value o0.05 was considered statistically significant. Relations between AER and cardiometabolic variables Seventeen obese women (6.3%) had microalbuminuria. Waist circumference, BP, insulin, fasting and 2 h glucose, HOMA-IR and triglycerides significantly increase in the tertiles of AER (Table 2 ). There were no significant differences in age, smoking habits, BMI, fat mass/fat-free mass ratio, GFR and HDL cholesterol.
Results
In the multivariate regression analysis with AER as dependent variable and all the variables in Table 2 Effect of 3-month lifestyle intervention on AER Twenty-nine obese women withdrew the intervention before the third month mostly due to working and family problems. Women who correctly followed the whole lifestyle program were divided into three groups according to the tertiles of changes in AER that corresponded to a decrease (tertile I), equality (tertile II) and increase (tertile III) in AER (Table 3) . At baseline women in the first tertile have higher AER levels and slightly higher HOMA-IR and insulin levels.
All groups achieved a significant reduction in BMI, waist circumference and sBP whereas only women in the first tertile had a significant improvement in 2 h glucose, insulin and HOMA-IR (Table 3) .
Of the 17 obese women, 8 with microalbuminuria became normoalbuminuric at the end of the intervention. These women, compared with those who remained microalbuminuric, showed significantly greater improvement in insulin Relations between AER and adipose tissue gene expression The baseline characteristics of the 34 nondiabetic obese women who underwent SAT biopsy are reported in Table 4 . Even within the low range of AER recorded in this group, there was a significant difference in HOMA-IR (3.7(1.8-6.0) vs 1.9(0.6-3.1), Po0.01), insulin (10.6(7.2-17.5) vs 7.6(3.1-13.5) mU l
À1
, Po0.05) and serum IL-6 (2.1±1.2 vs 1.1 ± 1.1 pg ml À1 , Po0.05) between women with AER greater and lower than the median level. No differences were noted Predictors of microalbuminuria in obesity L Gilardini et al in circulating levels of PTX-3, TNF-a and adiponectin between the two groups.
SAT of women with higher AER (and HOMA-IR levels) compared with that of women with lower AER levels showed significantly higher mRNA expression levels of SOCS-3 and PTX-3 and expressed more TNF-a (P ¼ 0.09) and angiotensinogen mRNA levels (Figure 1 ). No differences were noted between the two groups of women in ACE and adiponectin expression.
The mRNA expression levels of PTX-3 were correlated with those of SOCS-3 (r 0.451, Po0.01) and angiotensinogen (r 0.355, Po0.05) and both the expressions of SOCS-3 and PTX-3 were related to that of TNF-a (r 0.485, Po0.01 and r 0.395, Po0.05, respectively). 
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Discussion
This study showed that in nondiabetic obese women, weight loss alone does not determinate a decrease in AER that occurs only if accompanied by a concomitant improvement of glucose homeostasis. In addition, we observed an early association of AER with adipose tissue expression of proinflammatory adipokines involved in the development of insulin resistance and hypertension. This study is peculiar because it was conducted in a large group of nondiabetic obese women intentionally treated to obtain weight loss. To date, studies analyzing the effect of weight changes on microalbuminuria were not intentional to treat overweight 8, 21 or were performed in subjects with established renal disease 22 and/or diabetes 23 or were small in size. 11, 24 In this paper, we did not observe a relation between AER and GFR that was normal at baseline and did not change after weight loss. This finding diverges from what described in some 11, 12 but not all 8, 25 studies and suggests that metabolic alterations rather than altered glomerular dynamics promote the renal impairment. In fact, the improvement in glucose homeostasis and not the decrease in weight and BP was the independent predictor of AER decrease. Interestingly, we found that despite similar weight reductions, not all obese women had an improvement in insulin resistance. This finding agrees with the observation that a 6-month weight loss program induced an increase in insulin sensitivity measured by the euglycemic hyperinsulinemic clamp in obese subjects with insulin resistance and conversely led to a decrease in insulin sensitivity in metabolically healthy obese individuals. 26 In this context, in this Predictors of microalbuminuria in obesity L Gilardini et al study the improvement in glucose homeostasis and thereby a decrease in AER occurred in women with higher baseline HOMA-IR levels (not significant).
To ascertain what individual characteristics may be involved in the early renal impairment in subjects with similar degree of obesity, we analyzed the profile of expression of adipose tissue in relation to AER. Adipose tissue secretes a large number of multifunctional molecules and in obesity is early invaded by macrophages that contribute together with dysfunctional adipocytes to promote low-grade inflammation, insulin resistance and endothelial dysfunctions. 27 Hyperinsulinemia may participate in the development of nephropathy through several mechanisms that include stimulation of angiogenesis and proliferation of mesangial cells and the promotion of hemodynamic glomerular changes by its anti-natriuretic effects. 28 Obese women from whom SAT was obtained had low levels of AER that, however, were already associated with insulin and HOMA-IR levels. Furthermore, SAT of women with higher AER, compared with that of women with lower levels, showed a clear difference in the expression profile of proinflammatory molecules. In particular, higher AER was associated with higher SAT mRNA expression of SOCS-3 and PTX-3. SOCS-3 belongs the family of SOCS proteins that are induced by cytokines and participate in feedback loops that modulate cytokines action. 29 SOCS-3 is potent regulator of insulin signaling by competition for insulin binding to the activated insulin receptor, degradation of insulin receptor substrate proteins and inhibition of insulin receptor tyrosine kinase activity. 30 SOCS-3 has been shown to reduce insulin signaling in mice adipocytes 31 and to be robustly increased in the insulin sensitive tissues in animal models of insulin resistance. 32, 33 The few studies available in humans provided contradictory results on the function of SOCS-3 in the modulation of insulin sensitivity. 34, 35 Results in this paper support the existence of a positive association between the expression of SOCS-3 in human adipose tissue and insulin resistance. This finding agrees with the higher expression of SOCS-3 reported in SAT of obese subjects with insulin resistance. 34 Compared with women with lower AER, those with higher AER and SOCS-3 RNA expression in SAT also have higher circulating levels of IL-6 that is known to be an upregulator of the mRNA expression of SOCS3 in 3T3-F42A adipose cell line. 36 We did not measure the expression of IL-6 in adipose tissue; however, we noted that SOCS-3 expression was positively associated with that of other two proinflammatory adipokines, TNF-a and PTX-3, confirming the strict relation between the mechanisms underlying inflammation and insulin resistance within adipose tissue.
PTX-3 is an inflammatory mediator sharing a structural and functional homology with C-reactive protein. PTX-3 is produced by a variety of tissues and cells 37 and is considered an indicator of disease activity produced at sites. Within adipose tissue, PTX-3 is produced by macrophages, endothelial cells and adipocytes. 37, 38 In this study, we observed a positive relation between the expression of PTX-3 and TNF-a in SAT in accord with the demonstration that in 3T3-F442A adipocytes TNF-a is major inductor of PTX-3 gene expression and protein secretion. 39 In patients with diabetic nephropathy, plasma PTX-3 levels are associated with severity of proteinuria and impairment of endothelial function 40 and decrease in parallel with proteinuria after treatment with ramipril. 41 In this study, circulating levels of PTX-3 did not correlate with AER, likely because of the low contribution of fat tissue to circulating PTX-3 and of the lack of an overt nephropathy or systemic inflammation in obese women. However, we noted an interrelation among AER and adipose tissue expression of PTX-3 and angiotensinogen. The individual adipose tissue gene expression profile might be the consequence of the individual energy intake and adipose tissue hypoxia, both of which modulate the lipogenic pathways and the adipokine expression in fat tissue. 42, 43 In this context, an increased adipose gene expression of fatty acid synthase has been shown to be positively linked to microalbuminuria in type 2 diabetic patients 44 and to be upregulated in experimental chronic renal failure. 45, 46 We were not able to find an association between AER and both circulating and adipose mRNA levels of adiponectin. This finding diverges from the inverse relationship between AER and plasma adiponectin observed in obese African Americans. 18 It must be noted, however, that this negative relation was not confirmed in all studies and was even reported positive in other articles. 17, 47 In conclusions, our results showed that in obese nondiabetic subjects the reduction in AER is linked to the improvement of glucose homeostasis. This suggests that in nondiabetic obese patients, insulin sensitizing agents are worthwhile in addition to weight loss for the treatment of elevated AER. Furthermore, our results lend the credence to the hypothesis that the adipose tissue gene expression profile might favor the early renal impairment often seen in obese subjects.
